CAS 918407-35-9

Avoralstat

CAS : 918407-35-9

Avoralstat (BCX4161) is an oral plasma kallikrein (PKK) inhibitor. Which is used for the treatment of hereditary angioedema.

Formule : C₂₈H₂₇N₅O₅

Degré de pureté : 99.77%

Couleur et forme : Solid

Masse moléculaire : 513.54

Ref: TM-T14358

Avoralstat

CAS : 918407-35-9

Formule : C₂₈H₂₇N₅O₅

Degré de pureté : 98%

Masse moléculaire : 513.5445

Ref: IN-DA01EO4J

Avoralstat

CAS : 918407-35-9

Avoralstat

Degré de pureté : ≥95%

Masse moléculaire : 513.54g/mol

Ref: 54-BUP09041

Avoralstat

CAS : 918407-35-9

Formule : C₂₈H₂₇N₅O₅

Masse moléculaire : 513.55

Ref: 4Z-A-402001

3-(2-((4-CARBAMIMIDOYLPHENYL)CARBAMOYL)-5-METHOXY-4-VINYLPHENYL)-6-((CYCLOPROPYLMETHYL)CARBAMOYL)PICOLINIC ACID

CAS : 918407-35-9

Degré de pureté : 98%

Masse moléculaire : 513.5540161

Ref: 10-F858955

Avoralstat

CAS : 918407-35-9

Avoralstat is a small molecule that inhibits the serine protease of angiogenic and neovascular cells. It is an extracellular, inhibitory mechanism, reactive, neovascular inhibitor that binds to the catalytic site of neovascular cells. Avoralstat has been shown to be effective in eye disorders such as age-related macular degeneration and diabetic retinopathy. The molecular modeling studies have shown avoralstat's binding mode with serine protease. Avoralstat also has diagnostic properties that can be used in various diagnostic agents for different conditions such as cancer and inflammation.

Formule : C₂₈H₂₇N₅O₅

Degré de pureté : Min. 95%

Masse moléculaire : 513.54 g/mol

Ref: 3D-TLB40735